- Home
- BPOP vs HALO Comparison
BPOP vs HALO Comparison
Compare BPOP & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BPOP | HALO |
|---|---|---|
| Founded | 1893 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3B | 7.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BPOP | HALO |
|---|---|---|
| Price | $126.08 | $68.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | ★ $132.75 | $73.33 |
| AVG Volume (30 Days) | 567.0K | ★ 2.3M |
| Earning Date | 01-27-2026 | 11-03-2025 |
| Dividend Yield | ★ 2.38% | N/A |
| EPS Growth | 53.22 | ★ 56.68 |
| EPS | ★ 11.28 | 4.74 |
| Revenue | ★ $2,876,597,000.00 | $1,242,852,000.00 |
| Revenue This Year | N/A | $34.83 |
| Revenue Next Year | $20.92 | $24.84 |
| P/E Ratio | ★ $11.17 | $14.44 |
| Revenue Growth | 10.30 | ★ 31.19 |
| 52 Week Low | $78.23 | $46.76 |
| 52 Week High | $129.32 | $79.50 |
Technical Indicators
Market Signals| Indicator | BPOP | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 68.03 | 57.58 |
| Support Level | $115.52 | $61.23 |
| Resistance Level | $126.86 | $69.28 |
| Average True Range (ATR) | 2.31 | 1.72 |
| MACD | 0.70 | 0.66 |
| Stochastic Oscillator | 92.23 | 89.20 |
Price Performance
Historical ComparisonAbout BPOP Popular Inc.
Popular Inc, based in Puerto Rico, is a financial holding company with four main subsidiaries: Banco Popular de Puerto Rico, a bank in Puerto Rico in terms of assets; Banco Popular North America, its banking operation in the continental United States; Evertec, a data processor; and Popular Financial Holdings, a diversified financial services company. The Corporation's reportable segments consist of Banco Popular de Puerto Rico and Popular U.S.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.